University Hospitals of Derby & Burton NHS Foundation Trust
Derby, Derbyshire, DE22 3DT, United Kingdom
NCT Number: NCT04292015
ROP is a preventable cause of blindness in premature infants. It is routinely screened for by using an indirect ophthalmoscope, a scleral depressor, and a condensing lens. This method of screening can cause significant cardiorespiratory distress to infants. A new camera (Optos California) has recently been used to image infants with different severities of ROP. The Optos California is capable of capturing up to 200 degrees of retina in a single image without contact with the eye. The non eye contact nature of the Optos California may cause less distress to infants who are due a ROP screening examination. The present study is to compare the impact of ROP screening examination between the Optos retinal camera and conventional binocular indirect ophthalmoscopy using cardiorespiratory indices (such as heart rate, oxygen saturations, blood pressure, and respiratory rate) as a measure of distress.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Derby, Derbyshire, DE22 3DT, United Kingdom
This is a pilot prospective randomised study. As part of the routine clinical care at RDH, all premature infants eligible for ROP screening as stated by the UK ROP screening guidelines will undergo the gold standard screening examination by a Consultant Ophthalmologist.
Each infant eligible for ROP screening will be routinely scheduled for several ROP screening examinations prior to discharge from the neonatal unit. For each infant who is eligible and whose parent(s) or legal guardian have agreed for them to be enrolled in the study, two additional procedures to the gold standard examination with the binocular indirect ophthalmoscope (as stated above) will be carried out at each of its routinely scheduled ROP screening examination.
The first additional procedure will be the acquisition of images of both fundi by Ophthalmology Specialty Registrar with the Optos ultra-widefield retinal-imaging device. Cardiorespiratory indices will be collected at different time points of the Optos retinal imaging procedure.
The second additional procedure will be the collection of cardiorespiratory indices (including the heart rate,respiratory rate, oxygen saturations, and blood pressure) by the paediatric research nurse at the time of the gold standard examination with the binocular indirect ophthalmoscope. The equipment used will be the same as those used to measure the cardiorespiratory indices during different time points of the Optos ultra-widefield retinal imaging procedure (see above).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
retinal imaging device
Time frame: Baseline to 10 minutes following completion of both interventions
Blood pressure (BP)
Time frame: Baseline to 10 minutes following completion of both interventions
Defined as less than 100 beats per minute
Time frame: Baseline to 10 minutes following completion of both interventions
Number of infants who develop oxygen saturations below 85%
Time frame: Baseline to 10 minutes following completion of both interventions
Number of infacnts who develop respiratory distress, defined as respiratory rate less than 30 breaths per minute
Time frame: During intervention
Time of each intervention recorded
University Hospitals of Derby and Burton NHS Foundation Trust
Other
Impact of Retinopathy of Prematurity Screening Examination on Cardiorespiratory Indices - A Comparison of Optos Ultra-Widefield Retinal Imaging and Binocular Indirect Ophthalmoscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05243901
Development, Child, Female Urogenital Diseases and Pregnancy Complications
Paris, France
View Trial DetailsNCT04002908
Female Urogenital Diseases and Pregnancy Complications, Low Birthweight
Belagavi, India
View Trial DetailsNCT04633551
Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Columbia, South Carolina, United States
View Trial DetailsNCT05017727
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
London, United Kingdom
View Trial Details